Psoriasis
News
Early- and Late-Onset Psoriasis Differ Genetically
News
Alefacept Plus UVB Yields Sustained Benefit in Psoriasis
Major Finding: A PASI 75 response at week 16 was achieved in 45% of patients who received combination therapy, compared with 22% with alefacept...
Commentary
Blog: NIAMS Celebrates 25 Years of Progress
Original Research
An Open-Label, Multicenter Study of the Efficacy and Safety of an AM/PM Treatment Regimen With Clobetasol Propionate Spray 0.05% and Calcitriol Ointment 3 μg/g in the Management of Plaque Psoriasis
Psoriasis is a chronic condition with serious quality-of-life ramifications. Dermatologists seek alternative treatments of patients with plaque...
News
Topical Combo Shows Early Promise in Moderate Psoriasis
Major Finding: In a study of 168 patients, 50% of patients with moderate psoriasis who used a combination of calcipotriene 0.005% plus...
News
DMARDs for Psoriasis May Cut Diabetes Risk
Major Finding: The hazard ratios for diabetes were 0.62 for patients taking TNF inhibitors and 0.54 for patients taking hydroxychloroquine,...
News
Biologics Don't Increase Herpes Zoster Risk
Major Finding: No cases of herpes zoster occurred in psoriasis patients on alefacept (Amevive), efalizumab (Raptiva) or adalimumab (Humira).Data...
News
308-nm Excimer Laser Effective for Treating Palmoplantar Psoriasis
Major Finding: At the end of the treatments, all patients showed 50%-100% reductions in scaling, erythema, and flattened plaquesData Source: The...